Concepedia

Daniel C. Maneval

DC

Statistics

Publications

51

Citations

4K

H-Index

29

Active since

1988

Affiliations

Halozyme Therapeutics (United States)(Current)

Slovenska Industrija Jekla (Slovenia)

The University of Texas MD Anderson Cancer Center

Centre Antoine Lacassagne

St. Jude Children's Research Hospital

Daniel C. Maneval is an author at Halozyme Therapeutics (United States) specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

1988–2023

51

Publications

51

Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer

Michael A. Jacobetz, Derek Chan, Tashinga E. Bapiro et al. · Gut · 2012 · 1.1K citations · Full text

, , +17

Development and Characterization of Recombinant Adenoviruses Encoding Human p53 for Gene Therapy of Cancer

Ken N. Wills, Daniel C. Maneval, Patricia Menzel et al. · Human Gene Therapy · 1994 · 235 citations

, , +13

P53 tumor suppressor gene therapy for cancer.

Loretta L. Nielsen, Daniel C. Maneval · PubMed · 1998 · 218 citations

, , +16

Successful Adenovirus-Mediated Wild-Type <i>p53</i> Gene Transfer in Patients With Bladder Cancer by Intravesical Vector Instillation

Jürgen Kuball, Shu Fen Wen, Derek Atkins et al. · Journal of Clinical Oncology · 2002 · 123 citations

, , +17

A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells

Drake M. Mellott, Chien‐Te K. Tseng, Aleksandra Drelich et al. · ACS Chemical Biology · 2021 · 122 citations

, , +17

1–5 of 51